A trio of researchers at UMass Medical School in Worcester are attacking the coronavirus pandemic from three different angles, as part of a $17-million Massachusetts effort to help the world combat the disease which has killed more than 400,000 people globally.
Dr. Jeffrey Luban, a professor of molecular medicine at UMass Medical School
The researchers Dr. Robert Finberg, Dr. Ann Moormann, and Dr. Jeffrey Luban are studying ways to treat COVID-19, understand how it spreads, how people can be immune from its effects, and how herd immunity can be achieved.
We would like to know a little bit more about exactly how the virus causes the damage that it does, Finberg said.
The three UMass Medical School researchers are part of the Massachusetts Consortium on Pathogen Readiness, known as MassCPR, which is a statewide initiative including scientists and clinicians from Harvard University, the Massachusetts Institute of Technology, Boston University, Tufts University, University of Massachusetts, and local biomedical research institutes.
MassCPR is working to develop the infrastructure to address the COVID-19 pandemic. It was created through a research agreement between Harvard and the Evergrande Group in China, which is sharing financial support equally between Massachusetts research and researchers at the Guangzhou Institute of Respiratory Health in China. The funding is for five years.
MassCPR has obtained roughly $16.5 million to support and fund this first round of initiatives and projects. After receiving more than 400 applications for funding in March, MassCPR chose more than 60 applicants to receive funding, including the three at UMass.
This was obviously a very stiff competition, so anyone who actually received funding had an amazing application, said Professor David Golan from Harvard Medical School, one of the faculty co-leads of MassCPR.
According to UMass Medical School, projects selected were for their potential to influence clinical outcomes within the next 12 months. Luban, for example, a professor of molecular medicine at UMass Medical School, is researching the virologic mechanisms of COVID-19, attempting to discover what makes it unique. He aims to precisely understand infectiousness of coronavirus with his research.
Finberg, chair of the UMass Department of Medicine, is researching how to identify and target host cells and genes crucial in addressing the COVID-19 pandemic. His background in studying respiratory viruses makes researching COVID-19 a natural shift.
Dr. Robert Finberg, chair of the UMass Medical School Department of Medicine
The questions I was interested in are one, whether we can find a drug to treat the virus and the other was to find out exactly what cells the virus infects and what kind of cells respond to the virus, Finberg said in a phone interview.
His project funded by MassCPR focuses on specifically these two parts, how disease is caused and if there could be a viral treatment. Finberg does this through studying human samples.
Infectious disease can be defined in what cells the virus infects and what the host response is both cause disease, said Finberg.
Other than looking at the possibility of an antiviral agent to treat COVID-19 and how exactly the disease is caused, he is trying to understand how the virus works inside the body.
Part of Dr. Finbergs research has to do with finding so-called host targets that could be potentially drug targets that could help to prevent the infection of cells by the coronavirus, said Golan.
Moormann, a professor at UMass Medical School who focuses on infectious diseases and immunology, is looking into one of the most popular current research topics in relation to COVID-19, functional antibodies, which help the body fight off the disease.
Dr. Ann Moormann, a professor at UMass Medical School
Her study measures the spectrum of functional antibodies, how long these antibodies last for, and how they differ in people of different ages. Antibodies indicate past infections.
Part of the research I have funded is to look at the question of how long do the immunities to the virus that causes COVID-19 last, said Moormann.
Though looking at human samples to see how many antibodies currently exist in a person is part of this project, her research has a more longitudinal element where she looks at how the antibodies change over months, getting samples three, six, and nine months after the initial sample.
You can have an immune response that only protects you for a certain period of time, and it might be because your immune response doesnt become a memory response but it helps clear the infection We dont know how long [COVID-19 antibodies] last, said Moormann.
Moormann gets samples from patients who have recovered from coronavirus but also from people who were not diagnosed. She recruits study participants that are healthy and that are patients. She then tests to see whether or not the individual has antibodies.
Participants can choose to give a sample once, or, for those who want to be in the longitudinal part of the study, choose to come back in the following months to give more samples.
I want to look beyond [a few months]. Like in six months, in nine months, do you still have antibodies? Are you still protected? Moorman said.
Her research is a necessary part of understanding if and how herd immunity can be achieved to stop the COVID-19 pandemic.
Moormanns research is one of the very hottest topics right now in thinking about the pandemic, Golan said.
Its incredibly important for two reasons. One is when people get coronavirus infections, they develop the antibodies and its a question whether those antibodies protect you against another infection of coronavirus, said Golan.
Each of these doctors research projects aims to understand COVID-19 better so they are able to correctly fight against it which is why they obtained crucial funding from MassCPR.
MassCPR has been able to create a community of researchers and scientists in Massachusetts that have come together to better understand and control coronavirus. Golan said the collaboration and sharing of data between researchers is a key part of MassCPR and is already leading to important findings.
One thing that has been hugely highlighted by this pandemic is that we werent too well prepared for it, Golan said. Its our obligation to the next generation to be ready for the next one in a better way.
View post:
- Podcast 9 Athens part 3 and news - November 8th, 2009 [November 8th, 2009]
- Podcast 10 Athens part 4 - November 8th, 2009 [November 8th, 2009]
- Podcast 11 Athens Part 5 - November 8th, 2009 [November 8th, 2009]
- Episode 12 Cardiac Nuclear Medicine in the UK - November 8th, 2009 [November 8th, 2009]
- Podcast 13 Choline PET and prostate cancer - November 8th, 2009 [November 8th, 2009]
- Episode14 ED function and Dysponea - November 8th, 2009 [November 8th, 2009]
- ep 15 Collimator Choice and Reconstruction algorithm - November 8th, 2009 [November 8th, 2009]
- Episode 16 Dr Strauss on vulnerable plaque - November 8th, 2009 [November 8th, 2009]
- Episode17 Chemical Stress - November 8th, 2009 [November 8th, 2009]
- Episode 18 Myocardial Perfusion Imaging and Diabetes - November 8th, 2009 [November 8th, 2009]
- Episode 19 The INSPIRE trial - November 8th, 2009 [November 8th, 2009]
- 20 Dual isotope with a difference - November 8th, 2009 [November 8th, 2009]
- Episode 21 The real effect of stress - November 8th, 2009 [November 8th, 2009]
- Episode 22 D-SPECT - November 8th, 2009 [November 8th, 2009]
- Episode 23 VQ Reprise - November 8th, 2009 [November 8th, 2009]
- Episode 24 Hepatobiliary Nuclear Medicine - November 8th, 2009 [November 8th, 2009]
- Episode 25 Sleep Apnea - November 8th, 2009 [November 8th, 2009]
- Episode 26 Imaging Post Traumatic Stress Disorder - November 8th, 2009 [November 8th, 2009]
- Episode 27 Cardiac Stem Cells - November 8th, 2009 [November 8th, 2009]
- Episode 28 Molly Supply - November 8th, 2009 [November 8th, 2009]
- Episode 29 Melanoma therapy interview with Dr Ekaterina Dadachova - November 8th, 2009 [November 8th, 2009]
- Episode 30 Viral Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 31 breast radiotherapy using radioisotopes - November 8th, 2009 [November 8th, 2009]
- Episode 32 news from snm - November 8th, 2009 [November 8th, 2009]
- Episode 33 EBV Imaging and Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 34 Dr Lele SNM India 2009 - December 14th, 2009 [December 14th, 2009]
- Episode 35 Dr Andrew Scott from the Ludwig institute - January 10th, 2010 [January 10th, 2010]
- Episode 36 CardiArc - February 25th, 2010 [February 25th, 2010]
- Episode 37 Dr Modder Radiosynoviorthesis (Radiation Synovectomy) - March 31st, 2010 [March 31st, 2010]
- Episode 38 Indian Nuclear Medicine With Dr Malhotra and Dr Krishna - May 28th, 2010 [May 28th, 2010]
- Episode 39 Prof Ora Israel The Utility of Hybrid Imaging - July 13th, 2010 [July 13th, 2010]
- Episode 40 New V/Q SPECT developments - October 11th, 2010 [October 11th, 2010]
- Episode 41 scintimun - February 14th, 2011 [February 14th, 2011]
- Episode 42 Radio-Isotope Supply into the future - March 6th, 2011 [March 6th, 2011]
- Podcast 4: DNA therapy - April 24th, 2011 [April 24th, 2011]
- Sorry about the delay a new podcast will be out soon! - April 24th, 2011 [April 24th, 2011]
- Podcast 5 Flash 3D - April 24th, 2011 [April 24th, 2011]
- Podcast 6 Affibody - April 24th, 2011 [April 24th, 2011]
- Podcast 7 EANM 2006 Athens Part 1 - April 24th, 2011 [April 24th, 2011]
- Podcast 8 Athens Part 2 - April 24th, 2011 [April 24th, 2011]
- Episode 43 Rapidscan Part 1, 720P high quality video version - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Ipod quality video - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Audio version - May 1st, 2011 [May 1st, 2011]
- Episode 45 Mummies with cardiovascular disease video - May 21st, 2011 [May 21st, 2011]
- Episode 45 Mummies with cardiovascular disease audio edition - May 21st, 2011 [May 21st, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective - August 7th, 2011 [August 7th, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective audio version - August 7th, 2011 [August 7th, 2011]
- Episode 47 Cardiac Image Fusion With Dr Kaufmann - September 18th, 2011 [September 18th, 2011]
- Episode 47 Cardiac Fusion with Dr Kaufmann video version - September 18th, 2011 [September 18th, 2011]
- Dear Steve, I am and many more like me are your one more thing. - October 9th, 2011 [October 9th, 2011]
- EPISODE 48 PET MRI camera from Siemens with Dr Georgi audio - October 23rd, 2011 [October 23rd, 2011]
- EPISODE 48 PET MRI camera from Siemens Dr Georgi video - October 23rd, 2011 [October 23rd, 2011]
- Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit - April 25th, 2012 [April 25th, 2012]
- Leukaemia cells have a remembrance of things past - April 25th, 2012 [April 25th, 2012]
- Technologist Education Requirements Can Help Cut Repeat Scans - April 25th, 2012 [April 25th, 2012]
- HKU Collaborative Research Discovers A Novel Molecular Mechanism Of A New Anti-HIV-1 Drug Candidate - April 25th, 2012 [April 25th, 2012]
- Focal Segmental Glomerulosclerosis and the Nephrotic Syndrome - Part 1 Clinical - Video - May 4th, 2012 [May 4th, 2012]
- Electro-Medicine : Biological Physics - The Molecular Basis of Alzheimers Disease - Video - May 4th, 2012 [May 4th, 2012]
- osdd heterocyclic compounds and molecular medicines - Video - May 4th, 2012 [May 4th, 2012]
- Molecule to Medicine: The Biomarker Frontier - Video - May 4th, 2012 [May 4th, 2012]
- Fulfilling the Promise of Molecular Medicine in a Developmental Brain Disorder - Video - May 4th, 2012 [May 4th, 2012]
- Focus on Stefanie Dimmeler - Video - May 4th, 2012 [May 4th, 2012]
- Dundee - May 4th, 2012 [May 4th, 2012]
- Nanotechnology In Medicine: Huge Potential, But What Are The Risks? - May 5th, 2012 [May 5th, 2012]
- Cutting Edge Technology Coming To DMH - May 5th, 2012 [May 5th, 2012]
- This Week in Experimental and Molecular Pathology - May 5th, 2012 [May 5th, 2012]
- Researchers' discovery offers hope for cancer, heart disease miracle drugs - May 7th, 2012 [May 7th, 2012]
- Penn State student Zachary Hostetler from Garnet Valley is being honored as a student marshal - May 7th, 2012 [May 7th, 2012]
- NCKU Student Wins Prestigious Award for Anti-Cancer Research - May 10th, 2012 [May 10th, 2012]
- In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers ... - May 10th, 2012 [May 10th, 2012]
- Pitt team uses genomics to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- Genomics used to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- 2 molecular biologists get $500K medical prize - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists share $500K medical prize - May 13th, 2012 [May 13th, 2012]
- Lab21 Unveils New Molecular Analysis Services at Greenville Site - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists from NYC to share $500K medical prize for pioneering research on cells - May 13th, 2012 [May 13th, 2012]
- Two Molecular Biologists Get $500K Medical Prize - May 13th, 2012 [May 13th, 2012]
- Pair of molecular biologists receive Albany Medical Center Prize - May 13th, 2012 [May 13th, 2012]
- CNIO scientists successfully test the first gene therapy against aging-associated decline - May 16th, 2012 [May 16th, 2012]
- Cancer Institute of New Jersey Aims to Advance Personalized Cancer Treatments Through 'Precision Medicine' - May 16th, 2012 [May 16th, 2012]